rosiglitazone has been researched along with Cerebral Malaria in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, C; Friedel, M; Ho, KT; Kain, KC; Lu, Z; McDonald, CR; Mount, HT; Serghides, L; Sled, JG | 1 |
Ayi, K; Gowda, DC; Kain, KC; Liles, WC; Lu, Z; Patel, SN; Serghides, L | 1 |
John, CC; Kutamba, E; Mugarura, K; Opoka, RO | 1 |
Higgins, SJ; Kain, KC; Liles, WC | 1 |
2 review(s) available for rosiglitazone and Cerebral Malaria
Article | Year |
---|---|
Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.
Topics: Antimalarials; Arginine; Erythropoietin; Humans; Levamisole; Malaria, Cerebral; Malaria, Falciparum; Plasmodium falciparum; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazolidinediones | 2010 |
Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.
Topics: Africa; Antimalarials; Arginine; Clinical Trials as Topic; Dexamethasone; Epidemiologic Studies; Erythropoietin; Humans; Immunomodulation; Inflammation; Levamisole; Malaria, Cerebral; Malaria, Falciparum; Nitric Oxide; Plasmodium falciparum; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2011 |
2 other study(ies) available for rosiglitazone and Cerebral Malaria
Article | Year |
---|---|
PPARĪ³ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria.
Topics: Animals; Antimalarials; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Humans; Malaria, Cerebral; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; PPAR gamma; Randomized Controlled Trials as Topic; Real-Time Polymerase Chain Reaction; Ribonuclease, Pancreatic; Rosiglitazone; Thiazolidinediones | 2014 |
Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria.
Topics: Animals; CD36 Antigens; Flow Cytometry; Humans; Immunity, Innate; Leukocytes, Mononuclear; Macrophages; Malaria, Cerebral; Malaria, Falciparum; Mice; Phagocytosis; Plasmodium falciparum; Rosiglitazone; Signal Transduction; Survivors; Thiazolidinediones | 2009 |